Skip to content
TrialScanner

NCT06390410

A Pharmacokinetic Study of Simufilam in Subjects With Impaired Hepatic Function

Phase 1CompletedFLNALead

Registry record

Lead sponsor
Cassava Sciences, Inc.
Conditions
Hepatic Insufficiency
Primary completion
Dec 7, 2024Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT06390410 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT06390410: A Pharmacokinetic Study of... | TrialScanner